Pharmacists have developed a new drug called Regeneron to treat patients infected with the coronavirus, BBC writes.
A new and relatively expensive drug is a mixture of two types of antibodies obtained in the laboratory, which is administered intravenously and helps the body neutralize the virus.
The British Medicines research group Recovery Trial says that the drug helps every third patient infected with the coronavirus. Experts note that 6 out of every 100 patients survived.
The cost of the drug ranges from about 1 400 to 2 800 USD.
"Regeneron" is used only for the treatment of patients whose body does not produce antibodies independently.
In the UK, this drug has been tested on a thousand patients and has been found to significantly reduce: the risk of death as well as the risks of the need for hospitalization and resuscitation.
Sir Martin Landry, a professor of medicine and epidemiology at Oxford University and one of the study's lead authors, says that the new drug reduces the risk of death in critically ill patients by about one-fifth.
The new drug was used in combination with dexamethasone. A year ago, doctors found that dexamethasone alone reduced the risk of death by about a third among critically ill patients.
